Hyperprocalcitonemia is related to noninfectious postoperative severe systemic inflammatory response syndrome associated with cardiovascular dysfunction after coronary artery bypass graft surgery

被引:51
作者
Kerbaul, F
Guidon, C
Lejeune, PJ
Mollo, M
Mesana, T
Gouin, F
机构
[1] Grp Hosp Timone, Dept Anesthesie Reanimat Adulte, F-13385 Marseille 05, France
[2] Grp Hosp Timone, Dept Med Informat, F-13385 Marseille, France
[3] Grp Hosp Timone, Serv Chirurg Cardiaque, F-13385 Marseille 05, France
[4] Fac Med Marseille, INSERM U 38, F-13385 Marseille, France
关键词
cardiac surgery; inflammation; procalcitonin; organ dysfunction;
D O I
10.1053/jcan.2002.29672
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective: To investigate the role of 3 inflammatory parameters as early markers of severe systemic inflammatory response syndrome (SIRS) induced by coronary artery bypass graft surgery. Design: Prospective study. Setting: University hospital. Participants: Patients (n = 63) undergoing elective coronary artery bypass graft surgery with cardiopulmonary bypass. Measurements and Main Results: The American College of Chest Physicians/Society of Critical Care Medicine classification was used to diagnose SIRS. Organ system failures were used to define severe SIRS. Serum concentrations of the inflammatory parameters (procalcitonin [PCT], C-reactive protein, leukocyte count) were determined before, during, and after surgery. SIRS occurred in 30 (47%) patients after surgery. Seven patients (11%) showed SIRS with greater than or equal to1 organ dysfunction (severe SIRS), whereas patients without SIRS had no organ dysfunction. Significantly higher serum levels of PCT were found in patients with severe SIRS from the 6th postoperative hour until the 3rd postoperative day with a peak level of 10.7 +/- 13.2 ng/mL. No significant difference was detected between serum PCT of patients with SIRS but without any organ dysfunction and patients without SIRS. PCT levels of these patients remained lower than 1.7 ng/mL. Compared with PCT, plasma concentrations of C-reactive protein peaked later on the 2nd postoperative day and were not able to confirm the severity of SIRS. Leukocyte counts were not significantly modified. Conclusion: PCT seems to be an appropriate marker to identify the early development of noninfectious postoperative severe SIRS after coronary artery bypass graft surgery with cardiopulmonary bypass. Copyright 2002, Elsevier Science (USA). All rights reserved.
引用
收藏
页码:47 / 53
页数:7
相关论文
共 33 条
  • [1] Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations
    Aouifi, A
    Piriou, V
    Blanc, P
    Bouvier, H
    Bastien, O
    Chiari, P
    Rousson, R
    Evans, R
    Lehot, JJ
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 1999, 83 (04) : 602 - 607
  • [2] ARONEN M, 1990, INTENS CARE MED, V16, P128, DOI 10.1007/BF02575308
  • [3] Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules
    Asimakopoulos, G
    Taylor, KM
    [J]. ANNALS OF THORACIC SURGERY, 1998, 66 (06) : 2135 - 2144
  • [4] HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION
    ASSICOT, M
    GENDREL, D
    CARSIN, H
    RAYMOND, J
    GUILBAUD, J
    BOHUON, C
    [J]. LANCET, 1993, 341 (8844) : 515 - 518
  • [5] Diagnostic value of procalcitonin: the influence of cardiopulmonary bypass, aprotinin, SIRS, and sepsis
    Boeken, U
    Feindt, P
    Petzold, T
    Klein, M
    Micek, M
    Seyfert, UT
    Mohan, E
    Schulte, HD
    Gams, E
    [J]. THORACIC AND CARDIOVASCULAR SURGEON, 1998, 46 (06) : 348 - 351
  • [6] Increased preoperative C-reactive protein (CRP) values without signs of an infection and complicated course after cardiopulmonary bypass (CPB) operations
    Boeken, U
    Feindt, P
    Zimmermann, N
    Kalweit, G
    Petzold, T
    Gams, E
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1998, 13 (05) : 541 - 545
  • [7] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874
  • [8] Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF alpha and endotoxin levels early after thermal injury
    Carsin, H
    Assicot, M
    Feger, F
    Roy, O
    Pennacino, I
    LeBever, H
    Ainaud, P
    Bohuon, C
    [J]. BURNS, 1997, 23 (03) : 218 - 224
  • [9] Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates
    Chiesa, C
    Panero, A
    Rossi, N
    Stegagno, M
    De Giusti, M
    Osborn, JF
    Pacifico, L
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 26 (03) : 664 - 672
  • [10] A RANDOMIZED STUDY OF THE SYSTEMIC EFFECTS OF WARM HEART-SURGERY
    CHRISTAKIS, GT
    KOCH, JP
    DEEMAR, KA
    FREMES, SE
    SINCLAIR, L
    CHEN, E
    SALERNO, TA
    GOLDMAN, BS
    LICHTENSTEIN, SV
    CIMOCHOWSKI, GE
    GALLAGHER, MW
    FRANTZ, PT
    ENGELMAN, RM
    [J]. ANNALS OF THORACIC SURGERY, 1992, 54 (03) : 449 - 459